Tissue
|
Type of mutation
|
Control
|
E2a
|
DMBAb
|
E2 + DMBAc, d
|
---|
Number
|
%
|
Number
|
%
|
Number
|
%
|
Number
|
%
|
---|
Mammary gland
|
G:C → C:G
|
3
|
9
|
4
|
10
|
4
|
6
|
4
|
4
|
G:C → A:T
|
14
|
43
|
18
|
45
|
5
|
8
|
8
|
9
|
G:C → T:A
|
7
|
21
|
6
|
15
|
13
|
20
|
14
|
16
|
A:T → T:A
|
1
|
3
|
4
|
10
|
33
|
50
|
48
|
53
|
A:T → C:G
|
3
|
9
|
3
|
8
|
3
|
4
|
4
|
4
|
A:T → G:C
|
2
|
6
|
1
|
2
|
5
|
8
|
9
|
10
|
Frameshift
|
3
|
9
|
4
|
10
|
3
|
4
|
3
|
3
|
Tandem
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
Total mutants screened
|
33
|
100
|
40
|
100
|
66
|
100
|
91
|
100
|
Ovary
|
G:C → C:G
|
2
|
5
|
2
|
8
|
11
|
11
|
13
|
11
|
G:C → A:T
|
16
|
42
|
11
|
44
|
12
|
12
|
19
|
17
|
G:C → T:A
|
9
|
24
|
6
|
24
|
22
|
23
|
20
|
17
|
A:T → T:A
|
3
|
8
|
1
|
4
|
37
|
38
|
37
|
33
|
A:T → C:G
|
1
|
3
|
1
|
4
|
5
|
5
|
6
|
5
|
A:T → G:C
|
2
|
5
|
0
|
0
|
9
|
9
|
10
|
9
|
Frameshift
|
5
|
13
|
4
|
16
|
2
|
2
|
7
|
6
|
Tandem
|
0
|
0
|
0
|
0
|
0
|
0
|
2
|
2
|
Total mutants screened
|
38
|
100
|
25
|
100
|
98
|
100
|
114
|
100
|
-
aNo significant difference from control group
-
bSpectrum from DMBA-treated mice was significantly different from control and E2-only groups (p < 0.0001)
-
cSpectrum from the mice exposed to E2 and DMBA was significantly different from control and E2-only groups (p < 0.01 in ovary and p < 0.0001 in mammary gland)
-
dNo significant difference from DMBA group